Skip to main content

Study

Silymarin May Protect Liver Health in Seniors with Fatty Liver Disease

Silymarin, a natural extract from milk thistle, may help protect the liver and improve blood sugar control in seniors with liver issues.

Liver HealthHealthy AgingHerbal Remedies
Study Credibility: Low3.5/10Early findingsNot enough evidence yetTalk with your clinician
PublishedMay 2026Last reviewedMay 2026
Email this

Summary

In plain language

Recent research suggests that silymarin, a key component of the milk thistle plant, may offer significant benefits for seniors dealing with liver problems. This natural extract acts as an antioxidant, helping to protect liver cells from damage. The study found that silymarin could reduce liver dysfunction, potentially decrease liver-related deaths in those with cirrhosis, and improve blood sugar control in seniors with diabetes. With its potential to protect and support liver health, silymarin might be particularly beneficial if started early in cases of fatty liver disease. Seniors interested in exploring this option should consider discussing it with their healthcare providers.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study reviewed the effects of silymarin, a compound derived from milk thistle, on liver health. Researchers focused on its antioxidant properties and its potential to improve liver function.

  • Researchers found that silymarin helps reduce liver damage and may improve blood sugar levels in diabetics.

  • The study highlighted the importance of starting silymarin early in fatty liver disease for maximum benefits.

  • While the findings are promising, more research in humans is needed to fully understand its effects and any potential interactions with medications.

Seniors should discuss these findings with their healthcare providers, especially if considering silymarin as a supplement.

Research Quality Score

Scored May 10, 2026 using rubric v9_2026-04-08.

Assessment

The study is a narrative review of silymarin's effects on liver health, lacking a formal consensus methodology or systematic review process. It provides a general overview of silymarin's pharmacology and potential benefits but lacks rigorous evidence grading or structured expert consensus. The study's relevance to seniors is moderate, as it discusses liver health in older adults but is not exclusively focused on this population. The journal is reputable, but the study's methodological transparency and conflict of interest disclosure could be improved.

Category Breakdown

CategoryScoreRating
Consensus methodology3.3/10
Panel composition & bias0.0/10
Statistical methodsNot applicable to this type of study
Transparency & process5.0/10
Conflicts & funding5.0/10
Endorsement & adoption0.0/10
Relevance to chosen population5.0/10
Publishing body quality5.0/10

Additional Notes

The study is primarily a narrative review and lacks the methodological rigor of a systematic review or formal consensus document. It provides useful background information but should be interpreted with caution regarding its applicability to clinical practice.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.